Low-dose erythropoietin is effective and safe in children on continuous ambulatory peritoneal dialysis

Pediatric Nephrology

Volumn 11, Issue 3, 1997, Pages 350-352

  Yalçinkaya, Fato̧ ^a,b   Tümer, Necmiye ^a   Çakar, Nilgün ^a   Özkaya, Nuray ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Continuous ambulatory peritoneal dialysis; Hypertension; Recombinant human erythropoietin therapy

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADOLESCENT; ANEMIA; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMATOCRIT; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCHOOL CHILD; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ANEMIA; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMATOCRIT; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY;

EID: 0030992335     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050294     Document Type: Article

References (12)

1. Macdougall IC, Cavil I, Davies ME, Hutton RD, Coles GA, Williams JD (1989) Subcutaneous recombinant erythropoietin in the treatment of renal anemia in CAPD patients Contrib Nephrol 76:219-226
2. Faller B, Slingeneyer A, Waller M, Michel C, Grützmacher P, Müller HP, Barany P, Grabensee B, Issad B, Schmitt H, Meisl F (1993) Daily subcutaneous administration of recombinant human erythropoietin in peritoneal dialysis patients: a European dose-response study. Clin Nephrol 40:168-175
3. Hisano S, Kaku Y, Ueda K, Onoyama K (1992) Human erythropoietin in children undergoing continuous ambulatory peritoneal dialysis. Acta Paediatr Jpn 34:36-41
4. Lui SF, Law CB, Ting SM, Lai KN (1991) Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 36:246 - 251
5. Kleinman KS, Schweitzer SU, Perdue ST, Bleifer KH, Abels RI (1989) The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function. A double-blind, placebo-controlled trial. Am J Kidney Dis 14:486 - 495
6. Report of the Second Task Force on Blood Pressure Control in Children (1987) Pediatrics 79:1 - 25
7. Steffen HM, Brunner R, Müller R, Degenhardt S, Pollok M, Lang R, Baldamus CA (1989) Peripheral hemodynamics, blood viscosity and the renin angiotensin system in hemodialysis patients under therapy with recombinant human erythropoietin. Contrib Nephrol 76:292 - 298
8. Esbach JW, Abdulhadi MH, Browne JK (1989) Recombinant human erythropoietin in anemic patients with end-stage renal disease. Ann Intern Med 111:992 - 1000
9. Nissenson AR (1994) Erythropoietin treatment in peritoneal dialysis patients. Pent Dial Int 14 [Suppl 3]:63 - 68
10. Balaskas EV, Melamed IR, Gypta A, Bargman J, Oreopoulas DG (1992) Influence of erythropoietin on blood pressure in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 13 [Suppl 2]:553 - 557
11. Samtleben W, Baldamus CA, Bommer J, Fassbinder W, Nonnast-Daniel B, Gurland HJ (1988) Blood pressure changes during treatment with recombinant human erythropoietin Contrib Nephrol 66:114 - 122
12. Canadian Erythropoietin Study Group (1991) Effect of recombinant human erythropoietin therapy on blood pressure in hemodialysis patients. Am J Nephrol 11:23 - 26